At the time of writing, Wave Life Sciences Ltd [WVE] stock is trading at $8.63, up 6.54%. An important factor to consider is whether the stock is rising or falling in short-term value. The WVE shares have gain 2.74% over the last week, with a monthly amount glided 27.85%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Wave Life Sciences Ltd [NASDAQ: WVE] stock has seen the most recent analyst activity on July 28, 2025, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $24. Previously, Citigroup started tracking the stock with Buy rating on July 16, 2025, and set its price target to $16. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $10 on April 29, 2025. Wedbush initiated its recommendation with a Outperform and recommended $18 as its price target on April 08, 2025. Jefferies started tracking with a Buy rating for this stock on February 25, 2025, and assigned it a price target of $26. In a note dated October 16, 2024, Raymond James upgraded an Strong Buy rating on this stock but restated the target price of $22.
For the past year, the stock price of Wave Life Sciences Ltd fluctuated between $5.04 and $16.74. Currently, Wall Street analysts expect the stock to reach $22.14 within the next 12 months. Wave Life Sciences Ltd [NASDAQ: WVE] shares were valued at $8.63 at the most recent close of the market. An investor can expect a potential return of 156.55% based on the average WVE price forecast.
Analyzing the WVE fundamentals
According to Wave Life Sciences Ltd [NASDAQ:WVE], the company’s sales were 93.95M for trailing twelve months, which represents an -55.82% plunge. Gross Profit Margin for this corporation currently stands at 0.91% with Operating Profit Margin at -1.53%, Pretax Profit Margin comes in at -1.38%, and Net Profit Margin reading is -1.38%. To continue investigating profitability, this company’s Return on Assets is posted at -4.51, Equity is -0.78 and Total Capital is 2.45. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.14 points at the first support level, and at 7.65 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.91, and for the 2nd resistance point, it is at 9.19.
Ratios To Look Out For
It is important to note that Wave Life Sciences Ltd [NASDAQ:WVE] has a current ratio of 2.56. On the other hand, the Quick Ratio is 2.56, and the Cash Ratio is 2.39. Considering the valuation of this stock, the price to sales ratio is 14.62, the price to book ratio is 9.65.
Transactions by insiders
Recent insider trading involved Verdine Gregory L., Director, that happened on Jun 13 ’25 when 30000.0 shares were sold. Director, GREGORY VERDINE completed a deal on Jun 13 ’25 to buy 30000.0 shares. Meanwhile, Director HENRY CHRISTIAN O sold 10500.0 shares on Mar 20 ’25.
